Cambridge Investment Research Advisors’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-22,711
Closed -$2.16M 2347
2018
Q3
$2.16M Sell
22,711
-12,619
-36% -$1.08M 0.02% 664
2018
Q2
$2.73M Buy
35,330
+3,599
+11% +$270K 0.03% 538
2018
Q1
$2.19M Sell
31,731
-11,941
-27% -$911K 0.02% 602
2017
Q4
$3.26M Sell
43,672
-5,512
-11% -$353K 0.04% 424
2017
Q3
$3.11M Sell
49,184
-1,391
-3% -$86.4K 0.04% 398
2017
Q2
$3.23M Buy
50,575
+3,943
+8% +$248K 0.05% 361
2017
Q1
$3.07M Sell
46,632
-2,615
-5% -$180K 0.05% 330
2016
Q4
$3.39M Sell
49,247
-847
-2% -$60.7K 0.06% 283
2016
Q3
$3.53M Buy
50,094
+3,793
+8% +$284K 0.07% 282
2016
Q2
$3.51M Buy
46,301
+997
+2% +$73.3K 0.07% 257
2016
Q1
$3.11M Sell
45,304
-5,043
-10% -$363K 0.07% 269
2015
Q4
$4.4M Buy
50,347
+2,103
+4% +$180K 0.1% 185
2015
Q3
$3.91M Buy
48,244
+8,337
+21% +$726K 0.11% 183
2015
Q2
$3.55M Buy
39,907
+1,178
+3% +$103K 0.1% 204
2015
Q1
$3.36M Buy
38,729
+1,967
+5% +$165K 0.1% 210
2014
Q4
$3.11M Buy
36,762
+1,008
+3% +$78.8K 0.1% 199
2014
Q3
$2.52M Buy
35,754
+2,517
+8% +$179K 0.07% 261
2014
Q2
$2.3M Buy
33,237
+3,083
+10% +$217K 0.08% 251
2014
Q1
$2.26M Sell
30,154
-1,477
-5% -$111K 0.09% 227
2013
Q4
$2.22M Buy
31,631
+1,387
+5% +$90.6K 0.09% 209
2013
Q3
$1.87M Buy
30,244
+1,383
+5% +$89.4K 0.08% 231
2013
Q2
$1.78M Buy
+28,861
New +$1.74M 0.09% 216

Other funds holding ESRX

Cambridge Investment Research Advisors's ESRX Position: Q4 2018 in Review

Cambridge Investment Research Advisors sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 22,711 shares — an estimated $2.16M sold.

Cambridge Investment Research Advisors first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $4.4M in Q4 2015. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Cambridge Investment Research Advisors reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 22,711 Express Scripts Holding Company shares in Q4 2018, an estimated $2.16M.
  • Cambridge Investment Research Advisors first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • Cambridge Investment Research Advisors's Express Scripts Holding Company position peaked at $4.4M in Q4 2015.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.